Shieh, Perry B. et al "ASPIRO Gene Therapy Trial In X-Linked Myotubular Myopathy (XLMTM): Update on Preliminary Safety And Efficacy Findings up to 72 Weeks Post-Treatment (1053)." Neurology 94.15 Supplement (2020): 1053. Web. 08 Feb. 2023.